Treatment of cardiovascular disease may be more effective in the future due to a new scientific discovery.
Research which was presented at the American Heart Association Scientific Sessions 2011 found a new drug has the potential to lower cholesterol levels.
The trial of the drug, called evacetrapib, was conducted on people with high levels of LDL cholesterol and low amounts of HDL cholesterol – the ratio most likely to lead to the development of cardiovascular disease.
"This study indicates that evacetrapib may potentially have some effect on helping to lower bad cholesterol and improve good cholesterol levels in the blood," the British Heart Foundation's senior cardiac nurse Natasha Stewart said.
She also advised the use of statins to help lower levels of cholesterol in the blood.
According to the charity, as well as high cholesterol, the risk of a person developing cardiovascular disease increases if they smoke, have high blood pressure and are overweight.